Vanguard Group »

Keros Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $80M 1.8M 45.70
2024-03-31 $102M 1.5M 66.20
2023-12-31 $57M 1.4M 39.76
2023-09-30 $45M 1.4M 31.88
2023-06-30 $48M 1.2M 40.18
2023-03-31 $45M 1.0M 42.70
2022-12-31 $50M 1.0M 48.02
2022-06-30 $21M 772k 27.63
2022-03-31 $40M 737k 54.38
2021-09-30 $28M 710k 39.56
2021-06-30 $28M 668k 42.46
2021-03-31 $37M 603k 61.54
2020-12-31 $42M 592k 70.53
2020-09-30 $12M 299k 38.57
2020-06-30 $12M 312k 37.53